Combined cytogenetic and molecular genetic analyses of fifty-nine untreated human prostate carcinomas

Cancer Genetics and Cytogenetics

Volumn 90, Issue 1, 1996, Pages 37-44

  Zitzelsberger, Horst ^a   Szücs, Sandor ^b   Robens, Elisabeth ^b   Weier, Heinz Ulrich ^c   Höfler, Heinz ^a,b   Bauchinger, Manfred ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 16Q; CHROMOSOME 9; CHROMOSOME LOSS; CLINICAL ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TRISOMY; Y CHROMOSOME;

EID: 0030221143     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(96)00065-9     Document Type: Article

References (46)

1. Scardino PT, Weaver R, Hudson MA (1992): Early detection of prostate cancer. Hum Pathol 23:211-222.
2. Atkin NP, Baker MC (1985a): Chromosome 10 deletion in carcinoma of the prostate. N Engl J Med 321:315.
3. Atkin NP, Baker MC (1985b): Chromosome study of five cancers of the prostate. Hum Genet 70:359-364.
4. Gibas Z, Pontes EJ, Sandberg AA (1985): Chromosome rearrangements in a metastatic adenocarcinoma of the prostate. Cancer Genet Cytogenet 16:301-304.
5. Lundgren R, Kristoffersson U, Heim S, Mandahl N, Mitelman F (1988): Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate. Cancer Genet Cytogenet 35:103-108.
6. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F (1992): Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chrom Cancer 4:16-24.
7. Limon J, Lundgren R, Elfving P, Heim S, Kristoffersson U, Mandahl N, Mitelman F (1989): Double minutes in two primary adenocarcinoma of the prostate. Cancer Genet Cytogenet 39:191-194.
8. Brothman AR, Lesho LJ, Somers KD, Schellhammer PF, Ladaga LE, Merchant DJ (1989): Cytogenetic analysis of four primary prostatic cultures. Cancer Genet Cytogenet 37:241-248.
9. Brothman AR, Peehl DM, Patel AM, McNeal JE (1990); Fre-quency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50:3795-3803.
10. Brothman AR, Peehl DM, Patel AM, McDonald GR, McNeal JE, Ladaga LE, Schellhammer PF (1991): Cytogenetic evaluation of 20 cultured primary prostatic tumors. Cancer Genet Cytogenet 55:79-84.
11. Babu VR, Miles BJ, Cerny JC, Weiss L, Van Dyke DL (1990): Cytogenetic study of four cancers of the prostate. Cancer Genet Cytogenet 48:83-87.
12. Micale MA, Mohamed A, Sakr W, Powell IJ, Wolman SR (1992): Cytogenetics of primary prostatic adenocarcinoma. Cancer Genet Cytogenet 61:165-173.
13. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H (1993): Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 66:93-99.
14. Breitkreuz T, Romanakis K, Lutz S, Seitz G, Bonkhoff H, Unteregger G, Zwergel T, Zang KD, Wullich B (1993): Genotypic characterization of prostatic carcinomas: A combined Cytogenetic, flow cytometry and in situ DNA hybridization study. Cancer Res 53:4035-4040.
15. Peehl DM, Stamey TA (1986): Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 22:82-90.
16. Limon J, Lundgren R, Elfving P, Heim S, Kristoffersson U, Mandahl N, Mitelman F (1990): An improved technique for short-term culturing of human prostatic adenocarcinoma tissue for cytogenetic analysis. Cancer Genet Cytogenet 46:191-199.
17. Szücs S, Zitzelsberger H, Breul J, Bauchinger M, Höfler H (1994): Two-phase short-term culture method for cytogenetic investigations from human prostate carcinoma. The Prostate 25:225-235.
18. Henke RP, Krüger E, Ayhan N, Hübner D, Hammerer P (1994): Frequency and distribution of numerical chromosomal aberrations in prostate cancer. Hum Pathol 25:476-484.
19. Zitzelsberger H, Szücs S, Weier HU, Lehmann L, Braselmann H, Enders S, Schilling A, Breul J, Höfler H, Bauchinger M (1994): Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes. J Pathol 172:325-335.
20. Steilen H, Ketter R, Romanakis K, Zwergel T, Unteregger G, Bonkhoff H, Seitz G, Ziegler M, Zang KD, Wullich B (1994): DNA aneuploidy in prostatic adenocarcinoma: A frequent event as shown by fluorescence in situ DNA hybridization. Hum Pathol 25:1306-1313.
21. Brothman AR, Watson MJ, Zhu XL, Williams BJ, Rohr LR (1994): Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 75:40-44.
22. Brothman AR, Patel AM, Peehl DM, Schellhammer PF (1992): Analysis of prostatic tumor cultures using fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 62:180-185.
23. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB (1990): Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
24. ISCN (1991): Cancer cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Cytogenet Cell Genet VI: 54.
25. Weier HU, Segraves R, Pinkel D, Gray JW (1990): Synthesis of Y-chromosome specific labeled DNA probes. J Histochem Cytochem 38:421-426.
26. Jones C, Kao FT, Taylor RT (1980): Chromosomal assignment of the gene for folylpolyglutamate synthetase to human chromosome 9. Cytogenet Cell Genet 28:181-194.
27. Trask B, van den Engh G, Christensen M, Massa HF, Gray JW, van Dilla M (1991): Characterization of somatic cell hybrids by bivariate flow karyotyping and fluorescence in situ hybridization. Som Cell Mol Genet 17:117-136.
28. Sambrook J, Fritsch EF, Maniatis T (1989): Molecular Cloning. 2nd ed. New York: Cold Spring Harbor Laboratory Press.
29. Mitelman F (1991): Catalog of Chromosome Aberrations in Cancer, 4th ed. New York: Wiley-Liss, Inc.
30. Lindström E, Salford LG, Heim S, Mandahl N, Strömblad S, Brun A, Mitelman F (1991): Trisomy 7 and sex chromosome loss need not to be representative of tumor parenchyma cells in malignant glioma. Genes Chrom Cancer 3:474-479.
31. Elfving P, Cigudes JC, Lundgren R, Limon J, Mandahl N, Kristoffersson U, Heim S, Mitelman F (1990): Trisomy 7, trisomy 10, and loss of the Y chromosome in short-term cultures of normal kidney tissue. Cytogenet Cell Genet 53:123-125.
32. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB (1994): Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002.
33. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, Chung LWK, Liang JC (1994): Trisomy 7: A potential cytogenetic marker of human prostate cancer progression. Genes Chrom Cancer 9:19-27.
34. Jones E, Zhu XL, Rohr LR, Stephenson RA, Brothman AR (1994): Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chrom Cancer 11:163-170.
35. Sandberg AA (1992): Chromosomal abnormalities and related events in prostate cancer. Hum Pathol 23:368-380.
36. Van Dekken H, Alers J (1993): Loss of chromosome Y in pros tatic cancer cells, but not in stromal tissue. Cancer Genet Cytogenet 66:131-132.
37. Heim S, Mitelman F (1987): Cancer Cytogenetics, New York: Alan R. Liss.
38. Konig JJ, Teubel W, Vandongen JW, Romijn JC, Hagemeijer A, Schroder FH (1994): Loss and gain of chromosomes 1, 18, and Y in prostate cancer. The Prostate 25:281-291.
39. Lundgren R, Berger R, Kristoffersson U (1991): Constitutive heterochromatin C-band polymorphism in prostatic cancer. Cancer Genet Cytogenet 51:57-62.
40. Berger R, Bernheim A, Kristoffersson U, Mitelman F, Olsson H (1985): C-band heteromorphism in breast cancer patients. Cancer Genet Cytogenet 18:37-42.
41. Shabtai F, Antebi E, Klar D, Kimichi D, Hart J, Halbrecht I (1985): Cytogenetic study of patients with carcinoma of the colon and rectum: Particular C-band variants as possible markers for cancer proneness. Cancer Genet Cytogenet 14:235-245.
42. Rey JA, Bello MJ, de Campos JM, Benitez J, Valcarcel E, Castro PM (1985): C-banding studies in lymphocytes from patients with tumors. Cancer Genet Cytogenet 15:129-136.
43. Sandberg AA (1990): The Chromosomes in Human Cancer and Leukemia, 2nd ed. New York: Elsevier Science Publisher.
44. Atkin NP, Brito-Babapulle V (1983): Chromosome 1 C-band heteromorphisms in patients with carcinoma in situ and invasive carcinoma of the cervix uteri. Aust NZ J Obstet Gynaecol 23:73-76.
45. Eagle LR, Yin XY, Brothman AR, Williams BJ, Atkin NB, Prochownik EV (1995): Mutation of the MXI1 gene in prostate cancer. Nature Genetics 9:249-255.
46. Hermanek P (1986): Neue TNM/pTNM-Klassifikation und Stadieneinteilung urologischer Tumoren ab 1987. Urologe [B] 26:193-197.